Consistently, the level of aromatase protein as well as production of estrogen increased by IFNα or IFNβ treatment in SGBS preadipocytes but not in the ER-positive BC cell lines (Figs. 2b and c and S1b). The gene discussed is CYP19A1; the disease is breast cancer.